ClinicalTrials.gg

JW Pharmaceutical clinical trials

Also known as Choongwae.

Part of JW Holdings, which holds 44.61% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 77 studies whose lead sponsor is JW Pharmaceutical. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 13, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare JW Pharmaceutical with Humanis Saglık Anonim Sirketi and AstraZeneca →

Pipeline: 18 programs

Each counted once: 18 with a study JW Pharmaceutical leads registered in the last two years.

  • Phase 1
  • Phase 3
  • Phase 4 (approved, new studies)

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of JW Pharmaceutical’s own registered studies; JW Pharmaceutical’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs JW Pharmaceutical’s studies test, most open studies first — 23 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 13 more

Coming up

3 of JW Pharmaceutical’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 77 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now68%
  • Under way, not recruiting11%
  • Completed6584%
  • Stopped early23%Withdrawn 1 · Terminated 1
  • Status unknown or other34%

Phase

  • Phase 127
  • Phase 417
  • Phase 316
  • Phase 27

Where

  • Korea, Republic of69
  • United States5
  • United Kingdom3
  • Germany2
  • Japan1
  • Spain1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 823
  18. 24
  19. 25
  20. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to JW Pharmaceutical.

  • JW Pharmaceutical
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    77 studies

Studies

Recruiting first, then most recently updated. Showing 50 of 77. Browse all 77 →